Pharmacists' Role in the Comprehensive Care of Acute Coronary Syndrome
Provided by American Academy of CME, Inc.
This educational activity is supported by an educational grant from AstraZeneca.
July 24, 2019
July 24, 2020
Estimated time to complete activity
The scope of this online, enduring activity is to develop an online monograph designed for the clinical pharmacist involved in the daily care of patients with or at-risk of developing acute coronary syndrome (ACS). Through a detailed review, the online monograph will address key practice concerns for the pharmacist as well as assist in their development of effective patient education strategies. A key component of this initiative is to look at the shared decision-making process during ACS management, and the key role of the pharmacist as a member of the cardiology care team.
Pharmacists must become better aware of the numerous current guidelines and recommendations for managing patients with ACS and must increase their understanding of standard and newer therapies, their risks and benefits to better prepare management plans to optimize patient adherence to therapy and improve outcomes. By increasing their understanding and ability to apply this understanding surrounding antithrombotic therapies that can be the most effective in ACS in practice, they will improve quality of life and productivity for patients with ACS while reducing unnecessary hospitalizations and adverse events, improving outcomes through individualized patient management.
Toby C. Trujillo, PharmD, FCCP, FAHA, BCPS-AQ
Associate Professor, Cardiology
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado Anschutz Medical Campus
Clinical Specialist, Anticoagulation/Cardiology
Co-chair, Anticoagulation Subcommittee UC Health
University of Colorado Hospital
This activity has been designed to meet the educational needs of pharmacists; other healthcare professionals may also participate.
Upon completion of this educational activity, the participant should be better able to:
- Distinguish updated guideline recommendations for antithrombotic therapies for ACS and their role in pharmacy practice
- Identify appropriate evidence-based antithrombotic therapies and treatment pathways for individual patients with ACS
- Identify key clinical trial data surrounding the risks and benefits of standard, newer, and emerging antithrombotic agents for the treatment of ACS
- Improve patient understanding of available ACS treatments and the importance of adherence to therapy in order to improve outcomes and reduce healthcare costs
Accreditation and Credit Designation
Pharmacists and Physicians
American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. The Academy is also accredited by the Commission on Dietetic Registration, and is a Provider approved by the California Board of Registered Nursing.
This activity provides 2.0 contact hours (0.2 CEUs) of continuing education credit. ACPE Universal Activity Number (UAN): JA4008191-0000-19-005-H01-P.
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are able to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.
Disclosures are as follows:
Toby C. Trujillo, PharmD, FCCP, FAHA, BCPS-AQ Cardiology
- Advisory Board for Scientific information:
Portola Pharmaceuticals, Janssen Pharmaceuticals
- Consultant for Marketing Purposes:
Portola Pharmaceuticals, Janssen Pharmaceuticals, CSL Behring
- Advisory Board for Scientific information:
Sanofi, BD Pharmaceuticals
John JD Juchniewicz, MCIS, CHCP, Wendy Gloffke, PhD and Paul J. Miniter, MS
No relevant financial relationships with any commercial interests.
Michelle L. Kohute, Pharm.D., BCCCP
No relevant financial relationships with commercial interests.
This activity will not review off-label or investigational information.
The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information.
Method of Participation
There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CPE credit for your participation, please complete the post-test (achieving a passing grade of 70% or greater), and program evaluation. Your certificate can be printed immediately. For pharmacists, a statement of credit will be issued through CPE Monitor in 6-8 weeks. Only learners who provided valid NABP e-Profile ID numbers and month and day of birth (MMDD) will be submitted to CPE Monitor for official record of credit.
Please ensure the computer you plan to use meets the following minimum requirements:
- Operating System: Windows 98 or higher & Macintosh 2.2 or higher
- Internet Browser (Mac &/ Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
- Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
- Monitor Screen Resolution: 320 x 480 or higher
- Media Viewing Requirements: Adobe Reader, Microsoft Powerpoint, Flash Player & HTML5
For any questions, please contact: CEServices@academycme.org
© 2019. This CPE-certified activity is held as copyrighted © by American Academy of CME, Inc. Through this notice, the Academy grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).
Postgraduate Healthcare Education, LLC (PHE) is the source of Power-Pak C.E.® continuing education for health care
professionals. Our accredited programs assist in meeting the requirements of licensure. PHE provides continuing
education for the broad spectrum of health care professionals. This site features a searchable database of accredited
Power-Pak C.E.® courses on important topics for today's health care professionals.
PHE customizes Power-Pak C.E.® online for each visitor by creating a personal participant profile. Registered participants
may update their contact information, take an exam, receive instant grading, view their exam history, and print certificates
for successfully completed programs at any time. Monthly notifications will be sent to participants notifying you of new
courses available on the site.